Fibromatosis

subtype

Identifier: CI-CAN-00000890
Entity page: /cancer/fibromatosis ↗
Edges: 124

Neighbours: 16 drugs10 trials
Drawn: 26 of 26 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Fibromatosis investigated in trials for …INVESTIGATED_IN_TRIALSderived16 of 16show fewer
→ investigated in trials for	Nirogacestatsmall molecule 8 trials (4 active) · roll-up of the cancer and its descendants	—	—	Fibromatosis	8	Observed	clinicaltrials	graph →
→ investigated in trials for	Imatinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants

Fibromatosis studied in …STUDIED_INderived10 of 108show all (up to 200)
→ studied in	NCT07755176enrolling by invitation Patient-reported Outcomes Following Percutaneous Ablation of Desmoid Tumors · condition mapped ALIAS · 108 trials mapped (33 active)	—	—	Desmoid Fibromatosis	1	Observed	clinicaltrials	graph →
→ studied in	NCT07158892NA · not yet recruiting Understanding Patient Preferences When Deciding on a Voluntary Musculoskeletal Test · condition mapped ALIAS · 108 trials mapped (33 active)	—	—	Palmar Fibromatosis	1	Observed	clinicaltrials	graph →
→ studied in	NCT07170644Phase 2 · active not recruiting A Study of Nirogacestat in Japanese Adults With Desmoid Tumors/Aggressive Fibromatosis (DT/AF) · condition mapped ALIAS · 108 trials mapped (33 active)	—	—	Desmoid Fibromatosis	1	Observed	clinicaltrials	graph →
→ studied in	NCT07176689Phase 4 · recruiting Nirogacestat in Premenopausal Females With Desmoid Tumor/Aggressive Fibromatosis (DT/AF) · condition mapped ALIAS · 108 trials mapped (33 active)	—	—	Desmoid Fibromatosis	1	Observed	clinicaltrials	graph →
→ studied in	NCT05949099Phase 2 · recruiting Study of Cryoablation and Nirogacestat for Desmoid Tumor · condition mapped ALIAS · 108 trials mapped (33 active)	—	—	Desmoid Fibromatosis	1	Observed	clinicaltrials	graph →
→ studied in	NCT02402244recruiting Project: Every Child for Younger Patients With Cancer · condition mapped ONTOLOGY_EXACT · 108 trials mapped (33 active)	—	—	Desmoid Fibromatosis	1	Observed	clinicaltrials	graph →
→ studied in	NCT04851119Phase 1/Phase 2 · recruiting Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors · condition mapped CURATED_BROADER · 108 trials mapped (33 active)	—	—	Desmoid Fibromatosis	1	Observed	clinicaltrials	graph →
→ studied in	NCT03785964Phase 3 · completed Nirogacestat for Adults With Desmoid Tumor/Aggressive Fibromatosis (DT/AF) · condition mapped ALIAS · 108 trials mapped (33 active)	—	—	Desmoid Fibromatosis	1	Observed	clinicaltrials	graph →
→ studied in	NCT04195399Phase 2 · active not recruiting A Study of a New Drug, Nirogacestat, for Treating Desmoid Tumors That Cannot be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 108 trials mapped (33 active)	—	—	Desmoid Fibromatosis	1	Observed	clinicaltrials	graph →
→ studied in	NCT06330545NA · recruiting Radiation Therapy for Dupuytren's Contracture Following Non-Surgical Release · condition mapped ALIAS · 108 trials mapped (33 active)	—	—	Palmar Fibromatosis	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Strongest chains